MediFind
Condition

Multiple Endocrine Neoplasia

Symptoms, Doctors, Treatments, Research & More

Latest Research

Latest Advance
Study
  • Condition: Multiple Endocrine Neoplasia Type 1 (MEN1)-Related Hyperparathyroidism (PHPT)
  • Journal: Scientific reports
  • Treatment Used: Surgery
  • Number of Patients: 33
  • Published —
This study investigated short term surgical outcomes of multiple endocrine neoplasia type 1 (MEN1)-related primary hyperparathyroidism (PHPT).
Latest Advance
Study
  • Condition: Medullary Thyroid Carcinoma with Multiple Endocrine Neoplasia Type 2
  • Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
  • Treatment Used: Vandetanib and Cabozantinib
  • Number of Patients: 0
  • Published —
The study researched treatment methods for medullary thyroid carcinoma in patients with multiple endocrine neoplasia type 2.
Latest Advance
Study
  • Condition: Multiple Endocrine Neoplasia Type 2A (MEN 2A)
  • Journal: Endocrine
  • Treatment Used: Precision Medicine and Surgery
  • Number of Patients: 213
  • Published —
This study determined whether published disease penetrance estimates of 50% for pheochromocytoma and 20-30% for primary hyperparathyroidism in multiple endocrine neoplasia (MEN 2A) may be too high.
Latest Advance
Study
  • Condition: Metastatic Renal Cell Carcinoma (mRCC)
  • Journal: Endocrine
  • Treatment Used: Alternative Sunitinib Dosing 2/1 Schedule
  • Number of Patients: 42
  • Published —
This study evaluated thyroid profile during the alternative 2/1 SUN treatment schedule and assessed the predictive value of hypothyroidism in terms of survival in patients with metastatic renal cell carcinoma (mRCC).
Latest Advance
Study
  • Condition: MEN1-Associated Primary Hyperparathyroidism
  • Journal: Clinical endocrinology
  • Treatment Used: Single Gland Excision
  • Number of Patients: 89
  • Published —
This study tested the safety and efficacy of using a single gland excision to treat patients with MEN1-associated primary hyperparathyroidism.
Latest Advance
Study
  • Condition: MEN1-Related Pancreatic Neuroendocrine Tumors < 2 Centimeters
  • Journal: The Journal of clinical endocrinology and metabolism
  • Treatment Used: Lanreotide Therapy versus Active Surveillance
  • Number of Patients: 42
  • Published —
The study researched the effects of lanreotide therapy versus active surveillance for MEN1-related pancreatic neuroendocrine tumors < 2 centimeters.
Latest Advance
Study
  • Condition: Familial Medullary Thyroid Carcinoma (MTC)
  • Journal: Annals of surgical oncology
  • Treatment Used: Curative Resection
  • Number of Patients: 66
  • Published —
This study assessed the long-term outcomes after curative resection in patients with germline RET mutations and medullary thyroid cancer (MTC).
Latest Advance
Study
  • Condition: Gastric and Duodenopancreatic Neuroendocrine Tumor
  • Journal: World journal of surgery
  • Treatment Used: Surgical Resection
  • Number of Patients: 24
  • Published —
This study tested the safety and efficacy of using surgical resections to eliminate gastric and duodenopancreatic neuroendocrine tumors.
Latest Advance
Study
  • Condition: Insulinomas
  • Journal: Journal of endocrinological investigation
  • Treatment Used: Surgery
  • Number of Patients: 0
  • Published —
The study researched the diagnosis and treatment for insulinomas.
Latest Advance
Study
  • Condition: Multiple Endocrine Neoplasia (MEN) type 2A in Children
  • Journal: Journal of pediatric endocrinology & metabolism : JPEM
  • Treatment Used: Prophylactic Thyroidectomy
  • Number of Patients: 14
  • Published —
This study described the complications and long-term results in patients with multiple endocrine neoplasia type 2A (MEN 2A) syndrome in whom a prophylactic thyroidectomy was performed.
Latest Advance
Study
  • Condition: Japanese patients with refractory glaucoma
  • Journal: Eye (London, England)
  • Treatment Used: Endoscopic cyclophotocoagulation with 532-nm laser
  • Number of Patients: 10
  • Published —
The study researched the effects of endoscopic cyclophotocoagulation with 532-nm laser for Japanese patients with refractory glaucoma.